Home  Issuers' Corner  Press Releases  Pharmstandard
CLOSE

Press Releases > Pharmstandard  all about the company

company search
all press releases
all Pharmstandard press releases

Pharmstandard

October 11, 2012

Notice of 9 months 2012 sales results announcement day

Moscow, 11 October, 2012 –Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) will be announcing its 9 months 2012 sales results on Thursday, 25 October 2012.

Pharmstandard is pleased to invite the investment community to a sales results conference call with the management of the company followed by a Q&A session.

Thursday, 25 October, 2012 

09:00 New York

14:00 London

17:00 Moscow

International Call-in Number:+44 (0)20 7162 0025

US Call-in Number:+1 334 323 6201

Access Code: 923774

Conference call participants can register in advance using the link below:

https://eventreg1.conferencing.com/webportal3/reg.html?Acc=513832&Conf=185501

We recommend that participants start dialing in 5-10 minutes prior to ensure a timely start to the conference call.

Pharmstandard will be represented by:

Igor Krylov, CEO

Elena Arkhangelskaya, CFO
Ilya Krylov, IR
Conference call presentation and press release will be available on Thursday, 25 October 2012 on Company's web-site: https://pharmstd.com/
The conference call replay will be available throughOctober 31, 2012

International Replay Number: 020 7031 4064

Replay Access Code: 923774

Contacts:

Ilya Krylov
Investor Relations Officer
Pharmstandard OJSC
+7 495 970 00 30 ext.2416
E-mail: ir@pharmstd.ru
www.pharmstd.com

 

 

 

Search by industry

Agriculture, Foresty and Fishing | Chemicals | Engineering | Ferrous Metals | Financial, Insurance & Real Estate | Food & Kindred Products | General Construction | Information Technology | Media & Publishing | Non-Ferrous Metals | Oil & Gas | Pharmaceuticals | Power Industry | Precious Metals and Diamonds | Telecommunications | Transportation | Wholesale & Retail Trade

Search by alpha index

A B C D F G H I K L M N O P R S T U V W X Z



Site Map
© RUSTOCKS.com
Privacy Statement | Disclaimer